Based on the main difference in androgen levels, we hypothesized that MALAT1 expression in GCs might be downregulated in women with PCOS with hyperandrogenism, while MALAT1 level might be up-regulated in patients without hyperandrogenism and with high AMH. The gene discussed is AMH; the disease is hyperandrogenism.